Is Oxidized Low-Density Lipoprotein a Principal Actor in Atherogenesis?
Overview
Overview
Journal
Curr Med Chem
Publisher
Bentham Science Publishers
Specialty
Chemistry
Date
2024 Jan 8
PMID
38185888
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Kiani Z, Rouhani M, Mahdavi A, Askari G, Jamialahmadi T, Bagherniya M
. The effect of probiotics on oxidized LDL levels: A systematic review and meta-analysis of clinical trials. Curr Med Chem. 2023; .
DOI: 10.2174/0929867331666230815104548.
View
2.
Steinberg D
. Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem. 1997; 272(34):20963-6.
DOI: 10.1074/jbc.272.34.20963.
View
3.
Palinski W, Rosenfeld M, Yla-Herttuala S, Gurtner G, Socher S, Butler S
. Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci U S A. 1989; 86(4):1372-6.
PMC: 286692.
DOI: 10.1073/pnas.86.4.1372.
View
4.
Orekhov A, Tertov V, Kabakov A, Adamova IYu , Pokrovsky S, Smirnov V
. Autoantibodies against modified low density lipoprotein. Nonlipid factor of blood plasma that stimulates foam cell formation. Arterioscler Thromb. 1991; 11(2):316-26.
DOI: 10.1161/01.atv.11.2.316.
View
5.
AVOGARO P, Bon G, Cazzolato G
. Presence of a modified low density lipoprotein in humans. Arteriosclerosis. 1988; 8(1):79-87.
View